Please use this identifier to cite or link to this item:
https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/530
Title: | Exploring cancer patients', caregivers', and clinicians' utilisation and experiences of telehealth services during COVID-19: A qualitative study |
Authors: | Smith, S. J.;Smith, A. B.;Kennett, W.;Vinod, S. K. |
MNCLHD Author: | Kennett, William |
Issue Date: | Oct-2022 |
Citation: | Patient Education and Counseling. 2022 Oct;105(10):3134-3142. doi: 10.1016/j.pec.2022.06.001. |
Abstract: | Objectives: The COVID-19 pandemic has significantly impacted oncology. With pandemic restrictions limiting close contact between individuals, telehealth (the use of teleconferencing/videoconferencing to conduct real-time medical consultations) has been increasingly utilised. This qualitative study aimed to explore adult cancer patient, caregiver, and clinician (doctor, nurse, allied health) telehealth experiences during COVID-19 in urban and rural Australian settings and identify potential enablers and barriers to sustained telehealth implementation. Methods: English-speaking participants completed semi-structured interviews regarding their telehealth experiences since March 2020. Interviews ceased when data saturation occurred. Iterative thematic analysis was conducted using NVivo 12 Pro. Results: Thirty-four interviews (clinician=14, patient=13, caregiver=7) were conducted from April to August 2021. Analysis generated seven themes relating to telehealth use: 1) Acceptability as a form of consultation, 2) Impacts on healthcare provision, 3) Communication & relationships, 4) Efficient form of consultation, 5) Comfort of conducting telehealth in different environments, 6) Technological barriers and 7) Future preferences. Conclusions: The rapid uptake of telehealth during the pandemic has mostly been well-received, and telehealth can be appropriately used in oncology. Practice implications: Barriers including providing appropriate facilities, technology, and telehealth training; and selecting appropriate patients must be addressed to enable sustained telehealth use in future cancer care. |
URI: | https://mnclhd.intersearch.com.au/mnclhdjspui/handle/123456789/530 |
PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35688719/ |
DOI: | 10.1016/j.pec.2022.06.001 |
Keywords: | Pandemics;COVID-19;Telemedicine;Referral and Consultation;Videoconferencing;Neoplasms |
Appears in Collections: | Oncology / Cancer |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.